Silicon Valley Capital Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208K Buy
7,397
+35
+0.5% +$932 0.02% 99
2025
Q4
$183K Sell
7,362
-1,739
-19% -$43.9K 0.02% 92
2025
Q3
$232K Sell
9,101
-4,497
-33% -$111K 0.02% 83
2025
Q2
$330K Sell
13,598
-1,154
-8% -$26.9K 0.03% 72
2025
Q1
$372K Buy
14,752
+108
+0.7% +$2.83K 0.05% 59
2024
Q4
$389K Buy
14,644
+104
+0.7% +$2.82K 0.04% 66
2024
Q3
$421K Buy
14,540
+92
+0.6% +$2.68K 0.05% 60
2024
Q2
$404K Buy
14,448
+12,345
+587% +$340K 0.06% 59
2024
Q1
$58.4K Buy
2,103
+32
+2% +$888 0.01% 103
2023
Q4
$59.6K Buy
2,071
+27
+1% +$816 0.01% 93
2023
Q3
$67.8K Buy
2,044
+24
+1% +$849 0.01% 92
2023
Q2
$74.1K Buy
2,020
+21
+1% +$817 0.01% 89
2023
Q1
$81.6K Buy
1,999
+20
+1% +$864 0.02% 88
2022
Q4
$101K Buy
+1,979
New +$94.9K 0.02% 85
2022
Q1
Sell
-3,877
Closed -$229K 77
2021
Q4
$229K Buy
+3,877
New +$192K 0.04% 72
2021
Q2
Sell
-5,523
Closed -$200K 69
2021
Q1
$200K Sell
5,523
-770
-12% -$27.3K 0.04% 67
2020
Q4
$232K Buy
+6,293
New +$231K 0.05% 55

Other funds holding PFE

Silicon Valley Capital Partners's PFE Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its Pfizer (PFE) stake by 0.48% in Q1 2026, buying an estimated $932 and bringing the position to 7,397 shares worth $208K. The position accounts for 0.02% of the portfolio, ranked #99.

Silicon Valley Capital Partners first reported a position in PFE in Q4 2020 and has held it in 17 quarters since. The position peaked at $421K in Q3 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Silicon Valley Capital Partners held 7,397 shares of Pfizer worth $208K as of Q1 2026.
  • Silicon Valley Capital Partners bought 35 Pfizer shares in Q1 2026, an estimated $932.
  • Pfizer made up 0.02% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #99 holding.
  • Silicon Valley Capital Partners first reported a position in Pfizer in Q4 2020 and has held it in 17 quarters since.
  • Silicon Valley Capital Partners's Pfizer position peaked at $421K in Q3 2024.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.